Back to RL Rokos Capital Management LLP
NTLAShowing 1 of 11 quarters
Position history for RLRokos Capital Management LLP's holdings in INTELLIA THERAPEUTICS INC
No. Rokos Capital Management exited its NTLA (Intellia Therapeutics) position in Q3 2024. Its Q2 2024 13F listed 1,140,973 shares worth $25.5M. Rokos Capital Management first reported NTLA in Q1 2022 and held it in 10 quarterly 13F filings.
Final Value
$0
Final Shares
0
Total Value Change
$0
Total Shares Change
0
Quarter-by-Quarter History
Other major holders of NTLA: ARK Investment Management LLC